INNOVUS PHARMACEUTICALS, INC. Finite-Lived Intangible Assets, Gross
INNOVUS PHARMACEUTICALS, INC. had Finite-Lived Intangible Assets, Gross of $6.48 million as of 2019-09-30, per its 10-Q filed 2019-11-14.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization › Intangible Asset, Finite-Lived, after Accumulated Amortization › Intangible Asset, Finite-Lived, before Accumulated Amortization
us-gaap:FiniteLivedIntangibleAssetsGross · last filed 2019-11-14
- 2019-09-30: Finite-Lived Intangible Assets, Gross $6.48M.
- 2019-06-30: Finite-Lived Intangible Assets, Gross $6.48M.
- 2019-03-31: Finite-Lived Intangible Assets, Gross $6.48M.
- 2018-12-31: Finite-Lived Intangible Assets, Gross $6.45M.
| Period end | Finite-Lived Intangible Assets, Gross | Finite-Lived Intangible Assets, Gross as first filed |
|---|---|---|
| 2019-09-30 | $6.48M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $6.48M 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $6.48M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $6.45M 10-Q · filed 2019-11-14 | |
| 2018-09-30 | $6.20M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $6.20M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $6.20M 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $6.20M 10-K · filed 2019-04-01 | $6.20M 10-K · filed 2018-04-02 |
| 2017-09-30 | $6.20M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $6.20M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $6.20M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $6.20M 10-K · filed 2018-04-02 | |
| 2016-09-30 | $6.58M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $6.58M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $6.58M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $5.97M 10-Q · filed 2016-11-14 | |
| 2015-09-30 | $5.97M 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $5.97M 10-Q · filed 2015-08-14 | |
| 2015-03-31 | $5.97M 10-Q · filed 2015-05-15 | |
| 2014-12-31 | $1.17M 10-K · filed 2016-03-30 | |
| 2014-09-30 | $1.13M 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $1.13M 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $1.13M 10-Q · filed 2014-05-14 | |
| 2013-12-31 | $1.13M 10-K · filed 2014-03-28 |